Related Experiment Video
Updated: May 11, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Cyclooxygenase-2 in newborn hyperoxic lung injury
Rodney D Britt1, Markus Velten2, Trent E Tipple3
1Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA.
Insights
Cyclooxygenase-2 (COX-2) inhibition reduced inflammation in newborn mice exposed to high oxygen, but did not prevent lung developmental deficits associated with bronchopulmonary dysplasia (BPD). This suggests COX-2 may be a therapeutic target for BPD-related inflammation.
Area of Science:
- Neonatal physiology
- Pulmonary medicine
- Inflammation research
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in preterm infants, often caused by supraphysiological oxygen concentrations and mechanical ventilation.
- Hyperoxia exposure in newborn mice mimics BPD, leading to inflammation and impaired alveolarization.
- Pulmonary cyclooxygenase-2 (COX-2) expression is elevated in hyperoxia-exposed newborn mice.
Purpose of the Study:
- To investigate the role of COX-2 in hyperoxia-induced lung injury in newborn mice.
- To test the hypothesis that inhibiting COX-2 activity would reduce inflammation and improve alveolarization.
Main Methods:
- Newborn mice were treated with vehicle, aspirin, or celecoxib (COX-2 inhibitors) or used as wild-type, heterozygous, or homozygous COX-2 knockout models.
- Mice were exposed to room air or 85% oxygen for 14 days.
- Inflammatory markers, including monocyte chemoattractant protein-1 (MCP-1) and macrophage counts, were assessed in bronchoalveolar lavage fluid and lung tissue.
Main Results:
- Aspirin and COX-2 knockout mice showed reduced MCP-1 levels in bronchoalveolar lavage fluid.
- Aspirin and celecoxib treatments decreased macrophage infiltration and attenuated hyperoxia-induced COX activity.
- Despite reduced inflammation, COX-2 inhibition did not prevent hyperoxia-induced lung developmental deficits.
Conclusions:
- Increased COX-2 activity contributes to inflammatory responses, such as macrophage chemotaxis, during hyperoxia exposure.
- Modulating COX-2 activity may be a potential therapeutic strategy to mitigate hyperoxia-induced inflammation in preterm infants at risk for BPD.
- COX-2 inhibition alone does not fully prevent the lung structural damage associated with hyperoxia.
Abstract:
Supraphysiological O2 concentrations, mechanical ventilation, and inflammation significantly contribute to the development of bronchopulmonary dysplasia (BPD).Exposure of newborn mice to hyperoxia causes inflammation and impaired alveolarization similar to that seen in infants with BPD.Previously, we demonstrated that pulmonary cyclooxygenase-2 (COX-2) protein expression is increased in hyperoxia-exposed newborn mice.The present studies were designed to define the role of COX-2 in newborn hyperoxic lung injury.We tested the hypothesis that attenuation of COX-2 activity would reduce hyperoxia-induced inflammation and improve alveolarization.Newborn C3H/HeN micewere injected daily with vehicle, aspirin (nonselective COX-2 inhibitor), or celecoxib (selective COX-2 inhibitor) for the first 7 days of life.Additional studies utilized wild-type (C57Bl/6, COX-2(+/+)), heterozygous (COX-2(+/-)), and homozygous (COX-2(-/-)) transgenic mice.Micewere exposed to room air (21% O2) or hyperoxia (85% O2) for 14 days.Aspirin-injected and COX-2(-/-) pups had reduced levels of monocyte chemoattractant protein (MCP-1) in bronchoalveolar lavage fluid (BAL).Both aspirin and celecoxib treatment reduced macrophage numbers in the alveolar walls and air spaces.Aspirin and celecoxib treatment attenuated hyperoxia-induced COX activity, including altered levels of prostaglandin (PG)D2 metabolites.Decreased COX activity, however, did not prevent hyperoxia-induced lung developmental deficits.Our data suggest thatincreased COX-2 activity may contribute to proinflammatory responses, including macrophage chemotaxis, during exposure to hyperoxia.Modulation of COX-2 activity may be a useful therapeutic target to limit hyperoxia-induced inflammation in preterm infants at risk of developing BPD.
Related Concept Videos
Pneumothorax II: Pathophysiology
Atelectasis II: Pathophysiology
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Chronic Obstructive Pulmonary Disease II: Emphysema
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Oxygen Transport in the Blood